ANO1 and prostate carcinoma: In contrast, hemin has shown minimal impact on the cell viability of LNCaP (prostate cancer), A549 (lung cancer), and HepG2 (liver cancer) cells, which express negligible levels of ANO1, even at high concentrations (Figure 4D–F).